Case report: Immune-mediated meibomian gland dysfunction following pembrolizumab therapy for advanced urothelial carcinoma

Overview of attention for article published in Frontiers in oncology, October 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

facebook: 1 Facebook page

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 X post from an account with 467 followers.

New article: Case report: Immune-mediated meibomian gland dysfunction following pembrolizumab therapy for advanced urothelial carcinoma https://t.co/NMFxPyCQgi #MG #myastheniagravis #neurology https://t.co/uiipMYEzKH

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.